Company: IXHL
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001213900-25-036057
Chunk: 20

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 20
---
 Price of $0.216; (b)to consent to any adjustment to the exercise price (as low as the Floor Price of $0.216 per share) and/or number of shares of common stock underlying the Series A Warrants (from 11,574,090 to up to 115,740,900, assuming full adjustment of the exercise price to the Floor Price and beforegiving effect to the zero exercise price provision and up to 347,222,700 assuming full adjustment of the exercise price to the Floor Price and aftergiving effect to the zero exercise price provision) in the event of a Share Combination Event (i.e. any share split, reverse share split, share dividend, share combination recapitalization or other similar transaction involving the shares of our common stock), as defined and described below, without regard to any limitations upon exercise of the Series A Warrants relating to the Warrant Stockholder Approval and/or the provisions prohibiting adjustments in such Series A Warrants above the Floor Price of $0.216; (c)to consent to any adjustment to the exercise price of the Series A Warrants in the event of a voluntary adjustment described below; (d)to consent, without regard to any limitations upon exercise of the Series A Warrants relating to the Warrant Stockholder Approval and/or the provisions prohibiting adjustments in such Series A Warrants above the Floor Price of $0.216, to the zero exercise price provision of the Series A Warrant (which is referred to in the text of the Series A Warrants as an “alternative cashless exercise”) whereby, following the Warrant Stockholder Approval (even if a registration statement registering the issuance or resale of shares of common stock underlying the Series A Warrant is effective), the holder of a Series A Warrant has the right to receive, without paying any additional cash or consideration to the Company, an aggregate number of shares of common stock equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cash exercise of the Series A Warrant multiplied (which is subject to adjustment, as described above and below, to a number of shares that is up to 10 times the number of shares underlying the Series A Warrant at issuance) by (y) three (3.0); and (e)to consent to an increase in the number of shares of our common stock authorized for issuance under our Amended and Restated Certificate of Incorporation from 100,000,000shares to a minimum of